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 Abstract 
Interferons (IFNs) comprise a group of antiviral cytokines; however, their expression at the 
porcine maternal-fetal interface and in fetal tissues has not previously been investigated. The 
purpose of this study was to analyze the expression of type I IFNs and their receptors in maternal 
and fetal tissues from sows infected with PRRSV. The approach was to use real-time RT-PCR to 
identify the expression of different subtypes of type I IFN genes. The results show that the 
constitutive gene expression of some subtypes including IFN-α and IFN-αω were detected in 
fetal lymphoid nodes (IFN-αω), placenta (several IFN-α subtypes and IFN-ω5) and particularly, 
thymus (multiple IFN-α, IFN-δ and IFN-ω5).The results demonstrate that porcine type I IFNs are 
differentially expressed at the maternal-fetal interface and in fetal tissues in response to PRRSV 
infection.
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Chapter 1 - PRRSV literature review 
 Introduction 
Porcine reproductive and respiratory syndrome (PRRS) is one of the most economically 
important swine diseases. Infection with PRRS virus (PRRSV), the etiological agent of PRRS, 
results in reproductive failure in sows or gilts, respiratory distress, poor growth performance, and 
increased mortality in growing pigs. PRRSV strains can be classified into one of two genotypes, 
European genotype (EU or type I) and North American (NA or type II).  Innate immunity is the 
first line of defense against virus infections. Interferons (IFNs) are a group of innate immune 
effectors critical in regulation of antiviral responses. Three families, type I, II and III IFNs, have 
been identified, with type I IFNs containing the greatest number of subtypes and isotypes. Pigs 
have nearly 40 different type I IFNs. Although quite a few type I IFNs have already been 
identified, their expression at the maternal-fetal interface and fetal tissues during the later stages 
of fetal development have not been investigated. The purpose of this study was to make a 
detailed analysis of the expression of IFNs and their receptors in maternal and fetal tissues of the 
late gestation fetus during infection with PRRSV. The results provide a platform for 
investigating maternal-fetal immunity and for testing antiviral therapies. 
 The Arteriviradae Family 
The Arteriviradae family was first established in 1996, and consists of four enveloped, 
positive-stranded RNA viruses, which include lactate dehydrogenase elevating virus (LDV) of 
mice, equine arteritis virus (EAV), porcine reproductive and respiratory syndrome virus (PRRSV) 
and simian hemorrhagic fever virus (SHFV). Three viruses were first characterized in the 
1950s/1960s, while PRRSV was first identified in the early1990s. The consequences of infection 
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with arteriviruses range from asymptomatic infection to lethal disease. When PRRSV first 
appeared, it caused vast epidemics of reproductive and respiratory disease in both North 
American and European countries. Later, after  molecular analysis of isolates revealed that NA 
and EU viruses share only ~60% genetic identity. The two PRRSV genotypes might have 
evolved separately, but from a common ancestor (Knipe et al. 2007). 
 Porcine reproductive and respiratory syndrome virus (PRRSV) 
A new disease appeared in the late 1980’s, which was associated with reproductive 
failure and respiratory problems of piglets and growing pigs. The disease was called “mystery 
swine disease” in the US and “blue ear disease” in Europe. Later on, the North American and 
European investigators named the disease “porcine reproductive and respiratory syndrome” or 
PRRS. The causative agent was identified as a small enveloped, RNA virus (Lelystad Virus) 
(Wensvoort, et al. 1991). Almost simultaneously, a similar viral isolate, VR-2332, was identified 
in the US (Benfield, et al. 1992; Collins, et al. 1992). Lelystad-like isolates were placed in a 
group called type-I genotype viruses; whereas, isolates similar to VR-2322 were placed into the 
type-II genotype group.  
Under the electron microscope, PRRSV appears as a round particle with a relatively 
smooth surface (Snijder and Meulenberg 1998).The average diameter is about 55 nm without 
large surface projections commonly observed for other viruses  (Dokland, 2010). The envelope 
contains seven proteins: two major (M, GP5) and five minor species (GP2a, 2b, GP3, GP4, 5a). 
The envelope surrounds a nucleocapsid core, which contains the 15 kb RNA genome associated 
with the nucleocapsid protein (N) (Figure 1.2). All major and minor envelope proteins are 
required for the production of infectious virions (Molenkamp, et al. 2000; Knipe et al. 2007; 
Dokland, 2010). 
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The PRRSV genome is a 15 kb single-strand, positive-sense RNA [ss(+)RNA] flanked by 
a 5’ leader and a 3’ untranslated region followed by a poly-A tail (Figure 1.1). The major 
structural proteins, GP5, 5a, matrix (M) and nucleocapsid (N) are derived from ORFs 5, 6 and 7, 
respectively. GP2a, 2b, GP3 and GP4 are translated from ORFs2, 2, 3 and 4, respectively. 
Polyproteins, pp1a and pp1ab are encoded by ORF1a and ORF1b, which comprise 75% of the 
whole genome. PP1ab is proteolytically cleaved into at least 13 nonstructural proteins (Snijder 
and Meulenberg 1998). Autocatalytic processing is due to the three accessory cysteine 
proteinases, nsp1α, nsp1β and nsp2 and a serine protease, nsp4 (den Boon, et al. 1995; Ziebuhr, 
et al. 2000). The viral RNA-dependent RNA polymerase, helicase (Bautista et al., 2002) and 
uridylate-specific endoribonuclease are encoded by ORF1b and represent nsp’s 9-11, 
respectively (Nedialkova，et al. 2009).  In addition to involvement in virus replication, there is 
convincing evidence to show that nsp1α, nsp1β, nsp2, nsp4 and nsp11 can attenuate the type I 
IFN response (Beura, et al. 2010). 
The major proteins, M and GP5, comprise at least half of the viral proteins (Mardassi, et 
al. 1996; Dea, et al. 2000; Dokland 2010).   The M protein is a non-glycosylated 174 amino acid 
(173 for type-I viruses) protein containing a short 16-residue N-terminal signal peptide, a three 
transmembrane (TM) region and an 84-residue C-terminal endodomain ((Dokland 2010). The M 
protein is the most conserved structural protein of PRRSV (Meng, et al. 1995).  GP5 is a 
glycosylated 200-residue (201 for type-I) protein. It is the most variable structural protein of 
PRRSV, with only 51-55% peptide sequence identity between type 1 and type II viruses 
(Murtaugh, et al. 1995; Kapur, et al. 1996). It contains a N-terminal signal sequence, which after 
cleavage, leaves a very short, but heavily glycosylated, 30 amino acid ectodomain. The central 
hydrophobic region is assumed to span the membrane three times and is followed by a 
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cytoplasmic domain, which is about 50 to 75 amino acids long. Presumably, glycosylation 
functions to shield variable and conserved B cell epitopes. Recently, an additional AUG-initiated 
ORF was identified which overlaps the 5’ end of ORF5 and was named ORF5a. It codes for a 
43-64 amino acid protein and is the eighth structural protein of arteriviruses (Firth, et al. 2011).  
The 14 kDa N protein, derived from ORF7, is small (12-15kDa) and dominated by basic 
residues. It is believed that the N protein interacts with genomic RNA in its N-terminal domain 
during nucleocapsid assembly (Knipe et al. 2007). The protein is phosphorylated with 
phosphoserines identified in both RNA-binding and capsid-forming domains (Wootton, et al. 
2002; Knipe et al. 2007). 
There are four minor structural proteins on the PRRS virion. GP2 is 253 amino acid 
residues for type-I virus and 256 for type-II virus. GP2 contains a N-terminal signal sequence 
between residues 1-37 in type –I (1-40 in type-II), followed by a 168-residue ectodomain. GP2 
has two conserved glycosylation sites; however, glycosylation is not a prerequisite for viral 
infectivity (Meulenberg, et al. 1995; Wissink, et al. 2004; Dokland 2010). The small E or 2b 
protein is derived from ORF2b, which is fully embedded within ORF2 for type-II viruses (Wu, et 
al. 2001). E is non-glycosylated and 70-73 amino acids in length (Wu, et al. 2001; Wu, et al. 
2005). E consists of a single transmembrane helix and is predicted to form an oligomeric ion 
channel (Lee and Yoo 2006). The function of the ion channel is to lower the internal PH of the 
virus during fusion in the endosomal compartment (Gonzalez and Carrasco 2003). 
GP3 is a glycosylated integral membrane protein, which contains an uncleaved N-
terminal signal sequence and a hydrophobic C-terminal domain (Knipe et al. 2007). The overall 
sequence identity between type-I and type-II genotypes is only about 58%, and the highest 
divergence appears in the C-terminal 30-50 amino acid residues. It is predicted that GP3 contains 
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six glycosylation in a putative ectodomain region (Dokland 2010). All six glycosylation sites are 
used, which add about 16 kDa to its mass (Gonin, et al. 1998).  
The size of GP4 ranges from 178 (type-II) to 183 (type-I) residues (Meulenberg, et al. 
1997). It contains a predicted signal peptide, which cleaves the first 21 amino acids. Among the 
four glycosylation sites, at least three have been confirmed to possess glycans (Dokland 2010).  
GP2, GP3 and GP4 interact to form a multimeric complex within the envelope of the 
virus (both type-I and type-II) (Wissink, et al. 2005). GP2, GP3 and GP4 are disulfide linked in 
EAV, but this phenomenon has not been identified in PRRSV (Wieringa, et al. 2003; Wieringa, 
et al. 2004). All the minor proteins are required for the viral infectivity, but not all of them are 
required for the formation of the virus particle (Wissink, et al. 2005; Dokland 2010).  
 PRRSV replication 
Several cellular factors are required for the attachment and binding of the virus. Early 
investigation revealed that PRRSV matrix (M) protein binds heparin sulfate proteoglycans and 
heparin-like molecules on porcine alveolar macrophages (Jusa, et al. 1997). Virions are 
internalized via clathrin-coated vesicles and the genome RNA released following the 
acidification of vesicles (Nauwynck, et al. 1999). CD169 (procine sialoadhesin), a membrane 
glycoprotein that belongs to the siglec family of sialic acid binding immunoglobulin-like lectins, 
facilitates the internalization of virions (Vanderheijden, et al. 2003). This interaction between 
sialoadhesin (CD169) and PRRS virion is mediated through GP5/M. Recently, CD163, which 
belongs to the SRCR protein superfamily and interacts with PRRSV in the early endosome, plays 
a role in the uncoating and release of the virus genome (Welch and Calvert 2010).  
After entry into the cytoplasm, the genome is directly translated into pp1a and pp1ab 
polyproteins, which are cleaved into polypeptides with protease, replicase and scaffolding 
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functions (Molenkamp, et al. 2000). Replication complexes, formed in the perinuclear region of 
the cell are used to generate genome length minus strands (antigenomes), which generates 
positive sense genomes and subgenomic (sg) mRNAs.  
A nested set of sg mRNAs, which encode the structural proteins, share a common leader 
and polyA tail. The fusion of the leader, which is derived from the 5’ end of the genome, to the 
body incorporates a discontinuous RNA synthesis mechanism (Knipe et al. 2007). Conserved 
transcriptional regulatory sequences (TRSs) are present at the 3’ end of the leader sequence and 
at the 5’ end of the each transcriptional sg mRNA segment.  PRRSV acquires its envelope by 
budding of preformed nucleocapsids from the ER and Golgi complex (Magnusson, et al. 1970). 
After budding, the virions stay in intracellular vehicles, which are transported to the plasma 
membrane for release of virus progeny (Figure 1.3). 
 
 Adaptive immunity 
The humoral immune response following PRRSV infection is characterized by a robust 
production of non-neutralizing antibodies followed by the delayed production of a relatively 
weak neutralizing antibody response. PRRSV-specific Ab is detected in some pigs as early as 5-
7 days post-infection (DPI) and in all the pigs by 14 DPI (Yoon，et al. 1992). PRRSV-specific 
IgM reaches its peak by 14 DPI and then declines; whereas, IgG reaches its peak by 21-49 PI 
(Vezina, et al. 1996). Neutralizing activity appears at about 4 weeks after infection. The largest 
Ab response is against N and nsp2, which explains the weak neutralizing response (Mateu and 
Diaz 2008).  A variety of studies involving type I and type II isolates identify neutralizing 
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epitopes in GP5, GP4, M and GP3 (Gonin, et al. 1999; Cancel-Tirado, et al. 2004; Mateu and 
Diaz 2008). 
Cell-mediated immunity following PRRSV infection is characterized by a robust 
production of IFN-γ and to lesser extent IL-2 (Fuertes, et al. 1999). After vaccination of pigs 
with a type-II PRRSV strain, PRRSV-specific IFN-γ secreting cells first appear at about 3 weeks 
after infection. PRRSV-specific IFN-γ secreting cells are mainly CD4+CD8+ T cells, together 
with a small portion of CD8+ cytotoxic T cells (Meier, et al. 2003; Mateu and Diaz 2008). In 
addition to, IFN-γ, TNF-α and IL-12 can also be detected in alveolar macrophages and dendritic 
cells, along with increased IL-10 (Yoo, et al. 2010). 
Vaccines 
Live PRRSV vaccines are available for use in the USA. Generally, live attenuated 
vaccines can depress the severity of PRRS clinical signs and reduce viremia (Kimman, et al. 
2009). Protection is greater when the vaccine and challenge viruses are homologous (Kimman, et 
al. 2009; Meng 2000). Inactivated virus vaccines are generally considered non-protective 
(Kimman, et al., 2009; Zuckermann, et al. 2007; Kimman, et al. 2009).  The greatest challenges 
for vaccine design is to provide protection in the face of the large amount of antigenic variability 
offered by field strains and reduce the naturally occurring immune dysregulation.  For example 
live vaccines generate non-neutralizing antibodies, which are directed against the N protein 
(Thanawongnuwech and Suradhat 2010).  
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 Innate immunity 
The term “interferon” (IFN) was first used more than 50 years ago to describe a factor 
secreted by virus-infected cells that could protect neighboring cells from infection. The IFN 
family is composed of three classes, type I, II and III IFNs.  Type I and type III IFNs consist of 
multiple members and are important for antiviral innate immunity; whereas type II IFN has only 
one member, IFN-γ, and is mostly associated with adaptive immunity.  The porcine type I IFN 
genome locus contains at least 39 functional genes distributed along chromosomes 1 (SSC1) 
with one exception of IFN-κ on chromosome 10 (Sang, et al. 2010). Porcine type I IFNs contain 
multiple subclasses including 17 IFN-α subtypes, 11 IFN-δ subtypes, 7 IFN-ω subtypes, and 
single IFN-αω, IFN-β, IFN-ε, and IFN-κ (Pestka 2007). Among all identified type I IFNs, IFN-κ 
has the longest open reading frame encoding a 208-amino acid protein. All other type I IFNs 
encode 153-193 amino acid proteins (Sang, et al. 2010).  
Type I IFN production is initiated when single-stranded RNA is recognized by TLR8/9, 
which leads to the dimerization of receptors and recruitment of MyD88 into endosomes. The 
formation of signaling complexes involve the activation of the transcription factors, AP-1, 
Interferon regulatory factor 3/7 and NF-κB, which are translocated to the nucleus together with 
CBP. The results are the transcription of IFNα and IFNβ genes. IFNα and IFNβ bind to the type I 
IFN receptor, which consists of two units, IFNAR1 and IFNAR2.  The result is phosphorylation 
of Jak1 kinase, which phosphorylates Signal Transducers and Activators of Transcription 
(STAT) 1 and STAT2. STAT1 and STAT2 detach from the receptor and form a complex with 
ISG3 and IRF9. ISG3 translocates to the nucleus and binds ISRE to initiate the transcription of 
hundreds of ISGs (Sun, et al. 2012). Five major ISGs, MxA, OAS–1/RNaseL, RIG-I/MDA5, 
ISG15, and PKR, are responsible for suppression of viral infection.  
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 Type I IFNs during PRRSV infection 
  
Although PRRSV is highly sensitive to IFN-α, the virus has the ability to suppress the 
expression of type I IFNs. Suppression of IFN-β production has also been observed (Kimman, et 
al. 2009).  One action of PRRSV is to interfere with the activation of IFN-β promoter stimulator-
1 (IPS-1) in the retinoic acid-inducible gene I (RIG-I)(Luo, et al. 2008; Kimman, et al. 2009). 
PRRSV infection also inhibits the activation of interferon regulator factor 3 (IRF3), which plays 
a critical role in IFN-β transcription (Loving, et al. 2007; Genini, et al. 2008; Luo，et al. 2008).  
The ability of PRRSV to suppress type I IFN production is virus strain dependent (Lee, et al. 
2004; Yoo, et al. 2010). 
IFN production at the maternal-fetal interface influences fetal development and immunity. 
For example, a single injection of IL-2 and IFN γ into certain strains of mice can induce fetal 
resorption (Lala, 1990). Therefore, the induction of antiviral immunity presents an interesting 
paradox for the infected fetus. Cytokines that can protect the fetus from viral infection have a 
negative influence on fetal development. Three levels of IFN regulation control virus infection 
during pregancy: (1) induction of maternal-specific IFNs and adaptive responses for control of 
virus replication on the maternal side, (2) induction of placenta-specific IFNs to protect the 
fetuses, but proinflammatory responses may lead to fetal rejection, and  (3) induction of fetal 
IFNs and adaptive responses, which control virus replication at the level of the fetus. 
Understanding the family-wide expression of porcine type I IFNs at maternal-fetal interface and 
in fetal tissues will provide important information on how the fetus responds to viral infection 
during the late gestation period.  
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 A Pig model for the study of the maternal-fetal antiviral response 
As an experimental model of human disease pigs have many advantages. For example, 
pigs are physiologically and anatomically closer to humans. Many viruses that infect humans can 
also infect pigs. The gestation period and time to adulthood of pigs are relatively short (112 to 
114 days of gestation and about 6 months to sex maturity). Pig and human fetuses become 
immunocompetent during the last third of pregnancy. In this study, the expression of porcine 
type I IFNs was extensively analyzed in the immunocompetent pig fetus. Because there is no 
transfer of passive antibodies from mother to fetuses, PRRS virus isolation and serology can be 
used to estimate if the fetuses are infected in utero. The reproductive form of PRRS can result in 
severe consequences including increased regular and delayed returns to estrus, decreased 
conception, abortions, mummified fetuses, stillbirths and weak-born neonates. In this study, we 
use a real-time RT-PCR to examine the gene expression profile of type I IFNs to demonstrate the 
complex pattern of type I IFNs antiviral responses.  
 
 
 
 
 
 
  11 
 Figures and Tables 
Figure 1.1 Diagram of gene composition of PRRSV genome. 
 
Overview of PRRSV genome organization. The replicase open reading frames (ORFs) 1a and 1b 
are followed by the gene encoding the 2b protein, three genes (ORFs 5,6,7) encoding major 
structural proteins GP5, M and N, and the genes (ORF 2a, 2b, 3, 4) for the minor proteins GP2a, 
GP2b, GP3 and GP4. 
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Figure 1.2 The structure of the PRRS virion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Provided by Benjamin Trible) 
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Figure 1.3 PRRSV life cycle.  
 
(Adopted from John Patton) 
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Table 1.1 RT-PCR primer sequences for porcine type I, type III interferons and type-I 
interferon receptors 
Subtype Primer name and   
sequence (5’ to 3’) 
 Product size 
(bp) 
IFNα1 Sense 
Antisense 
GGCTCTGGTGCATGAGATGT 
GCCTTCTTCCTGAATCTGTCTTA 
337 
IFNα2 Sense  
Antisense 
CAACCTCAGCCTTCCTCACA 
GAATCTGTCTCACAGGTTTC 
549 
IFNα3 Sense 
Antisense 
TGAGGAGAATCTCCCCT 
CTTCCTGAATCTGTCTCA 
432 
IFNα4 Sense 
Antisense 
TCTCTGGGCTGCGACCCGGT 
CCTCCTGAGTCTGTCTTG 
502 
IFNα5/6 Sense 
Antisense 
GCACAAATGAGGAGAATATCT 
CCTCCTGAGTCTGTCTTG 
437 
IFNα7/11 Sense 
Antisense 
GGGACTTTGGATCCCCTCAT 
GTGGAGGAAGAGAAGGATG 
369 
IFNα8 Sense 
Antisense 
AACCTCAGCCTTCCTCACG 
GTCTGTCTTGCAGGTTTG 
546 
IFNα9 Sense 
Antisense 
GTGCTGCTCAGCTGCAAG 
AGTCCTCCTCCAGCAGGGGC 
384 
IFNα10 Sense 
Antisense 
TCTCTGGGCTGCGACCCGGT 
CTTCCTGAATCTGTCTCA 
502 
IFNα12 Sense CCTCAGCCTTCCTCACGGT 509 
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Antisense CTCATGACTTCTGCCCTGAT 
IFNα13/14 Sense 
Antisense 
TCCCCTCATGAGGCCTTTG 
CAGGTGTCTGTCACTCCTTC 
401 
IFNαω Sense 
Antisense 
AGATCTTCCGCCTCTTCAGCACAA 
TTCTGGTTTCCACCCTGACAACCT 
261 
IFNAR1 Sense 
Antisense 
ACCACAGTGAAACATCACCTGCCT 
TGTTGATGACGGGAGGAAACAGGA 
349 
IFNAR2 Sense 
Antisense 
TCAACGGGAATCAGAGTCGTCAGA 
TCAGGAAATACCCAGGCGGACAAT 
180 
IFNβ Sense 
Antisense 
ATGTCAGAAGCTCCTGGGACAGTT 
AGGTCATCCATCTGCCCATCAAGT 
246 
IFNδ1 Sense 
Antisense 
TATAAGCTTCTGGCAGGAGT 
AGCCTTGAGTCATCTTGT 
205 
IFNδ3/4/5 Sense 
Antisense 
AGAACTTGTCTGCTGTCCATT 
TTTGGAGAAGACACCGGA 
209 
IFNδ8/9 Sense 
Antisense 
ATGCTCTGCTCCACTCCTGC 
GTGCCTTGAGTCATCTGGATTGG 
194 
IFNε Sense 
Antisense 
TTGGTACTGCTGGCTTCTTCCACT 
AACTGCCCTGAAGAGGCTGAAGAT 
255 
IFNκ Sense 
Antisense 
GCAGAATGAGCCATTCGTTTCCCA 
TCCTCTTCCTCCTGCAAGCATTGT 
259 
IFNω1 Sense 
Antisense 
TGGTGCTTCTGCGTCAGATG 
CTCACCTGCACCAAGCAGGAC 
265 
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IFNω3 Sense 
Antisense 
TGTGTTCTCTCTACTGACGGTC 
CAGATGTCTGCTCTCCCATC 
389 
IFNω5 Sense 
Antisense 
TCATGCTCTCTCTACTGACAGC 
TGGAGCTTGTCCAGGAGGA 
300 
IFNL3 Sense 
Antisense 
AAGAGGGCCAAGGATGCCTTTGAA 
AGGCGGAAGAGGTTGAACATGACA 
374 
SCMHI Sense 
Antisense 
CACGGAGGCGCAGTCGTCTC 
GTACCTGGCGTGGCCGTGAG 
177 
 
 
 
 
 
 
 
  
  17 
Table 1.2 Porcine type-I and type-III IFN family members and the their functions 
Subtype Isotype Receptor Function Anti-PRRSV-activity 
IFNα 17 
IFNAR1 
IFNAR2 
IFNα and IFNβ 
stimulate both NK cells, 
macrophages and some 
other cell types to elicit 
an antiviral response  
IFNα provide nearly full 
protection against PRRSV 
infection 
IFNβ  1 IFNβ shows effective 
protection (60%~80%) 
IFN αω  1 
IFN αω is an unique 
porcine IFN subtype, 
exerting antiviral 
protection 
IFNαω, a unique porcine IFN 
subtype, also found anti-
PRRSV activity (~40%) 
IFN δ 11 IFN δ has high 
antiproliferative activity 
IFN δ shows low-anti-
PRRSV activity (20%~60%) 
IFN ε  1 
IFN ε mediates TNF-
alpha induced STAT1 
phosphorylation and 
induction of  RIG1 
IFN ε shows little antiviral 
activity against PRRSV 
(<20%) 
IFN ω  7 
IFN ω to date the exact 
biological activities and 
the physiological role of 
this interferon are 
unknown 
IFN ω shows low-anti-
PRRSV activity (20%~60%) 
IFN κ 1 
IFN-κ induces TNF-α, 
IL-10 and MCP-1 
production by monocytes 
IFN κ shows little antiviral 
activity against PRRSV 
(20%) 
IFN λ3  1 IL28a 
IFN λ3 has antiviral 
activity and up-regulates 
of MHC class I 
expression 
IFN λ3 also has anti-PRRSV 
activity 
 (Modified from Chang et al (2006), Takaoka and Yanai (2006), Sang et al (2010a, b). 
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Chapter 2 - Materials and methods 
 Virus and infection: 
Experiments involving animals were approved by the Kansas State University IACU 
Committee. Two PRRSV strains, the low-pathogenic KS483 and the high-pathogenic 72109, 
were used for infection of sows. The high-pathogenic 72109 was isolated during am abortion 
storm in East Kansas. Pregnant dams were infected with PRRSV at 90 days of gestation. Fetuses 
were collected at 112 days of gestation. The methods for the preparation of the PRRSV inoculum 
on MARC-145 cells and infection of pigs are described in Rowland et al. (2003). Briefly, virus 
was cultivated on MARC-145 cells in MEM supplemented with 7% FBS and antibiotics. Dams, 
at 90 days gestation were challenged with approximately 10⁵ TCID50 of virus diluted in 5ml of 
culture medium. One half of the inoculum was administered by intramuscular injection in the 
neck. The remaining dose was administered intranasally. As comparative controls, one mock-
infected dam was administered MARC-145 culture medium. Between 109 and 112 days of 
gestation of the 114 days gestation period, dams were sacrificed. For the collection of fetuses, the 
uterine horns were immediately removed after euthanasia. Beginning at the tip of each uterine 
horn, individual fetuses with intact placenta were carefully removed and immediately necropsied. 
A sample of amniotic fluid was collected prior to removal. Tissue samples were collected and 
stored in RNAlater (Ambion) for RT-PCR of cytokines mRNAs. PRRSV specific antibodies 
were measured using a commercial ELISA performed at the Kansas State University Veterinary 
Diagnostic Laboratory. Serology results were reported as a sample/positive (S/P) ratio. A ratio 
greater than 0.4 was considered positive for PRRSV-specific antibody. 
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 RT-PCR to detect virus (Ct value):  
The PRRS virus load in serum or thoracic fluid was assayed using a commercial semi-
quantitative real-time reverse transcriptase polymerase chain reaction (qRT-PCR) kit (ABI, 
Foster City, California, USA), performed by the Kansas State Veterinary Diagnostic Laboratory 
(KSVDL). A series of sample buffer containing known concentrations of cDNA template were 
included as a standard. PCR reactions were considered positive if the cycle threshold (Ct) level 
was <40 cycles. The results were reported as the number of templates per 50 µl reaction, which 
is approximately equal to the number of templates per ml of serum or thoracic fluid. 
 RT-PCR for detection the expression of type I IFN genes: 
Tissues samples for RT-PCR were immediately placed in RNAlater (Ambion) and stored 
at -80°. Total RNAs were extracted from the tissues (lung, lymph node, placenta and thymus). 
Following the protocol for RNA extraction using TRI reagent (Sigmaalderich, St. Louis). In 
brief, about 500 mg of tissues were homogenized in 1 ml of TRI reagent until it reached a liquid 
phase. Homogenates were transfered to DNAse/RNnase free 1.5 ml tubes. After standing at room 
temperature for 5-30 min, the homogenate was centrifuge at 12,000 g for 10 min. The 500 μl 
upper aqueous phase containing RNA were collected into new tubes and mixed with 50 ul of 
(1/10 of the TRI reagent) of 1-bromo-3-chloropropane. The mixtures were shaken vigorously for 
15 sec and stood for 2~15 min at room temperature. After centrifuge at 12,000g for 15 min at 4 
°C, the RNA in the aqueous phase was precipitated with addition of 500 ul of 2-propanol and 
collected by centrifugation. The RNA pellets were washed once with 70% alcohol and processed 
for treatment with 5 U RQ DNase (1/100 ul) to remove potential trace amounts of contaminated 
genomic DNA. The purified RNA was determined by a Nano-spectrometer, gel-electrophoresis 
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and BioAnalyser (BioLegend). The qualified RNA samples were stored at -80 °C until use as 
templates for RT-PCR detection.    
Real-Time RT-PCR analysis of IFN gene expression: 
Gene-specific primers were designed based on multiple alignments of related IFN 
sequences. Real-time RT-PCR arrays were performed in 96-well microplates. Reactions were 
conducted with a SYBR Green RT-PCR system (Qiagen, Valencia, CA) with 200 ng of total 
RNA in a 20ul reaction mixture and RT-PCR conditions described as following. The reverse 
transcription step was set at 50° for 10 min, following with PCR initial activation step at 95° for 
5min, the two-step cycling was set at 95° for 10s, 60° for 30s with 40 cycles. Critical threshold 
(Ct) values and melt curves were monitored and collected with StepOne Plus software (Applied 
Biosystems). Relative gene expression data in different tissues (lung, lymph node, thymus, 
placenta) were normalized against Ct values of the housekeeping gene (SCMHI), and the relative 
expression index (2
-ΔΔCt
) was determined in order to get the log2 value compared with the 
average expression levels of control samples. 
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Figure 2.1 Experimental design 
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Chapter 3 - Results 
 Fetal map 
A map showing the location and infection status of individual fetuses is shown in Figure 
3.1. In total, 14, 17 and 12 fetuses were obtained from Sow A, Sow B and Sow C, respectively. 
All the fetuses from Sow A Group were confirmed to be uninfected. Tissues from fetuses 1, 3, 4, 
5, 6, 7, 8 and 9 were used for analysis. For Sow B Group, 10 fetuses were found to be RT-PCR 
positive and seronegative, 4 fetuses were RT-PCR negative and seronegative, 1 fetus was RT-
PCR positive and seropositive and 2 fetuses were dead. Tissues for IFN analysis were obtained 
from fetuses 1, 4, 5, 11, 12, 14 and 15. For Sow C, 8 fetuses were found to be RT-PCR positive 
and seronegative, two fetuses were RT-PCR positive and seropositive, 1 fetus was dead and 1 
fetus was uninfected. Tissues from fetuses 2, 3, 4, 5, 7, 9, 12 were chosen for IFN expression 
analysis.    
Type-I IFN gene expression in tissues of uninfected fetuses   
The first study was to examine the expression of type I IFNs in the lung, lymph node, 
placenta and thymus from 8 uninfected fetuses. All IFNs were detected in all tissues. Mean 
values for IFN gene expression for the different tissues are shown in the Figure 3.2. There was 
variation in gene expression between subtypes. The lowest amounts of mRNA were found for 
IFNA3, IFNA10 and IFNL3. The highest amount of RNA was obtained for IFNW5, and we can 
observe that the gene expression of type I IFNs shows viability among different IFN subtypes 
and different tissues. Differences were also observed between tissues. Statistically different 
levels of expression were observed for IFNAR2 in thymus versus placenta (p=0.001), and for 
IFNB between lymph node and placenta (p=0.04).  
IFN gene expression during PRRSV infection.  
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     Fetuses were infected with two different PRRSV strains, KS483, a historical PRRSV isolate, 
and KS72109, a more contemporary virus isolated during an abortion storm. Figure 3.3 shows 
results for IFN gene expression in infected fetuses. The data are presented as the level of 
expression relative to the control fetuses. Differences between the two viruses were evident for 
lung and lymph node. Overall, the trend was a relative decrease in IFNA isotype expression in 
fetuses infected with KS72109. For the lung, the only statistically significant differences were 
increased IFNE and IFNW1 in KS72109 fetuses.  In contrast, the KS72109 fetuses showed 
increased expression in IFNA. The only significant difference was increased IFNB in the 
KS72109 fetuses.  
For placenta and thymus, there was an overall downregulation of IFN gene expression. 
Significant downregulation was observed for IFNA13/14 and IFNAR2 in thymus of fetuses 
infected with KS72109.  
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 Figures and Tables 
Figure 3.1 Fetuses map 
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Figure 3.2 Expression of porcine type I IFNs in uninfected fetuses  
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 Figure 3.3 Differential expression of porcine type I IFNs and type III IFN in infected 
fetuses. 
Gene expression is shown for different tissues from KS483-infected (grey bars) and KS72109-
infected (black bars) fetuses. The levels of expression are relative to the mean value obtained for 
control fetuses. 
 
 
 
 
 
KS483 
KS72109 
 
E
x
p
re
ss
io
n
 i
n
d
ex
 c
o
m
p
ar
ed
 t
o
 c
o
n
tr
o
l 
g
ro
u
p
 
  27 
Chapter 4 - Discussion 
Type I IFNs represent a critical group of antiviral molecules showing evolutionary gene 
expansion. Each mammalian species could possess 15-60 functional genes encoding multiple 
IFN protein, which are involved in developmental processes and antimicrobial activities (Sang Y, 
2010). Pigs possess at least 39 functional type I IFN genes. In this study, the expression of all 
IFN genes was detected in all tissues. As shown in Figure 3.2, there were differences in the level 
of expression between tissues. Not all members of the IFNA subtype were expressed to the same 
levels. Compared to the expression of the housekeeping gene, IFNA 7/11 were expressed at high 
levels than IFNA-10.  
PRRSV infection resulted in alterations of the expression pattern. In tissues, such as lung 
and lymph node, there were distinct differences in the patterns of the two viruses. The KS72109 
virus showed an overall reduction in IFNA isotypes compared to uninfected fetuses. However, 
the same virus produced increased levels of IFNA in lymph nodes.  IFNAW, the subtype only 
found in pigs and cattle, was down-regulated in lymph nodes of fetuses during PRRSV infection. 
The most consistent observation was the down-regulation of IFNA isotypes in placenta.  Almost 
all IFNs were down-regulated in the thymus.  
PRRSV infection showed less effect in suppression of type I IFNs in lymph nodes. 
Notably, PRRSV infection also significantly suppressed the expression of IFNAR1 and IFNAR2 
genes in the fetal thymus, indicating porcine thymus in addition to the lung may be another 
major target for PRRSV exerting immune subversion through targeting suppression both type I 
IFN production and action.  In the fetal lungs, most members of IFNA subtype, as well as in the 
thymus, showed different levels of suppression; in contrast, most other subtypes of IFND, IFNE, 
INFK and IFNW were up-regulated in the PRRSV infected tissues. This tissue- and IFN 
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subtype-dependent differential expression as shown in the fetal thymus and lung was further 
verified in the lymph nodes and placenta. Interestingly, IFNAR2 gene was more up-regulated 
compared to other subtypes in the placenta. Located at the maternal-fetal interface, placenta is an 
immune privilege site to limit over-proinflammatory responses to protect fetal development. 
Therefore, the upregulation of IFNAR gene expression other than increase of proinflammatory 
IFN ligands could be a feature of placenta in response to viral infection. Indeed, recent studies 
showed that IFNAR density is a key factor for the modulatory activity of type I IFNs (Moraga et 
al., 2009) in different cell types, implying that IFNAR expression level should be also considered 
for modulating antiviral activity of type I IFNs, particularly in fetuses or at maternal-fetal 
interface.                    
PRRSV have evolved multiple mechanisms targeting porcine type I IFN system 
including the components in IFN production and action signaling. The suppression of IFNA and 
IFNB subtypes by PRRSV has been demonstrated in both porcine alveolar macrophages and 
peripheral pDCs infected in vitro as well as in pigs infected in vivo  (Sun, 2012). It was reported 
that by inactivating IPS-1 which is a molecule involved in the RIG-1 pathway, PRRSV can 
interfere the nuclear translocation of IRF-3. Studies have also shown that the over expressed of 
nonstructural proteins (Nsp) 1, 2, 4, 11 can interfere the nuclear translocation of IRF-3 and the 
promoter activity of IFN β (Wang, 2012).  
The data presented here demonstrated for the first time about the differential expression 
of family-wide porcine type I IFNs in response to PRRSV infection in the fetal tissues and the 
placenta. Firstly, in comparison to the uninfected fetuses, PRRSV infection in general showed 
significant suppression of some IFNA subtypes in the fetal thymus. However, PRRSV infection 
  29 
showed less effect in suppression of type I IFNs in lymph nodes and lung.  The result indicates 
that the type I IFN responses in the fetal tissues were dependent on the different isolates. 
      In conclusion, these results demonstrate that (1) type-I IFNs shows differential 
expression profile in different kinds of tissues; (2) porcine type I IFNs and their subtypes are 
differentially expressed in fetal tissues upon PRRSV infection during the third phase of gestation; 
(3) the differential expression of type I IFN genes upon PRRSV infection is dependent on the 
pathogenicity of viral isolates. 
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